Author

Cell Culture Drug Resistance Testing

Table 2 - Raw Data/Clinical Correlations with Cell Death Assays

Author	Dx	N	TP	TN	FP	FN	Reference
Leone	Adrenal	1	0	1	0	0	[1]
Beksac	ALL	3	2	1	0	0	[2]
Bosanquet	ALL	1	0	0	1	0	[3]
Bosanquet	ALL	17	14	2	1	0	[3]
Hongo	ALL	25	16	3	5	1	[4]
Hongo	ALL	133	90	18	20	5	[5]
Kaspers	ALL	58	40	6	0	12	[6]
Larsson	ALL	4	1	2	1	0	[7]
Lathan	ALL	4	3	1	0	0	[8]
Weisenthal	ALL	29	18	5	2	4	[9]
Weisenthal	ALL	2	2	0	0	0	[10]
Kirkpatrick	ALL&CLL	55	38	7	10	0	[11]
Bosanquet	AML	4	0	1	2	1	[3]
Langkjer	AML	11	6	5	0	0	[12]
Larsson	AML	21	11	8	2	0	[7]
Santini	AML	27	6	13	0	8	[13]
Sargent	AML	21	10	9	2	0	[14]
Larsson	AML/ALL/N	73	45	16	9	3	[15]
Beksac	ANLL	12	7	3	2	0	[2]
Hongo	ANLL	14	9	1	2	2	[4]
Hongo	ANLL	14	9	2	1	2	[16]
Lathan	ANLL	17	11	4	1	1	[8]
Santini	ANLL	27	12	12	2	1	[17]
Tidefelt	ANLL	34	20	11	2	1	[18]
Leone	Bladder	2	0	2	0	0	[1]
Blackman	Breast	47	31	13	3	0	[19]
Koechli	Breast	17	9	6	1	1	[20]
Cree	Breast	29	17	5	4	2	[34]
Weisenthal	Breast	4	2	2	0	0	[10]
Bosanquet	CLL	80	12	48	18	2	[3]
Larsson	CLL	1	1	0	0	0	[7]
Silber	CLL	15	11	3	0	1	[21]
Weisenthal	CLL	15	9	4	1	1	[9]
Weisenthal	CLL	3	2	1	0	0	[10]
Bosanquet	CLL/ALL/N	226	102	76	41	7	[22]
Weisenthal	CML	9	2	6	1	0	[9]
Asanuma	COL/STO/N	23	1	17	5	0	[23]
Furukawa	Colon	16	3	13	0	0	[24]
Weisenthal	Colon	1	0	1	0	0	[10]
Weisenthal	Esophagus	1	0	1	0	0	[10]
Weisenthal	Small Cel	1	1	0	0	0	[10]
Leone	Gastroint	5	0	4	1	0	[1]
Meitner	Head and	18	13	1	2	2	[25]
Leone	Hyperneph	1	0	1	0	0	[1]
Leone	Melanoma	3	3	0	0	0	[1]
Weisenthal	Melanoma	1	0	1	0	0	[10]
Furukawa	Solid (Ms	22	1	18	3	0	[26]
Bosanquet	Myeloma	7	0	7	0	0	[3]
Weisenthal	Myeloma	6	2	2	1	1	[9]
Weisenthal	Myeloma	5	0	5	0	0	[10]
Larsson	Myelofibr	1	1	0	0	0	[7]
Beksac	NHL	1	1	0	0	0	[2]
Bosanquet	NHL	10	3	3	3	1	[3]
Leone	NHL	3	2	0	1	0	[1]
Nygren	NHL	50	27	10	11	2	[27]
Weisenthal	NHL	10	6	3	1	0	[9]
Weisenthal	NHL	3	0	3	0	0	[10]
Leone	NSCLC	8	5	2	1	0	[1]
Smit	NSCLC	6	0	6	0	0	[28]
Weisenthal	NSCLC	8	0	8	0	0	[10]
Wilbur	NSCLC	25	7	11	5	2	[29]
Meitner	Gynecolog	4	0	3	1	0	[25]
Blackman	Ovary	72	31	27	13	1	[19]
Carstensen	Ovary	22	6	12	4	0	[30]
Sargent	Ovary	25	9	9	6	1	[31]
Sevin	Ovary	31	23	6	0	2	[32]
Sevin	Ovary	65	45	12	3	5	[33]
Taylor	Ovary	37	11	17	6	3	[35]
Weisenthal	Ovary	3	1	2	0	0	[10]
Weisenthal	Pancreas	2	0	2	0	0	[10]
Leone	Renal	1	1	0	0	0	[1]
Leone	Sarcoma	2	1	1	0	0	[1]
Beksac	SCLC	1	1	0	0	0	[2]
Smit	SCLC	8	2	4	0	2	[28]
Weisenthal	SCLC	10	0	7	3	0	[10]
Furukawa	Stomach	22	3	16	3	0	[24]
Leone	Teratoma	1	0	1	0	0	[1]
Leone	Testicula	3	2	1	0	0	[1]
Leone	Thymoma	1	1	0	0	0	[1]
Leone	Unknown P	3	1	2	0	0	[1]

N=1603 TP=782 TN=536 FP=207 FN=77 Sens = .72 Spec = .91

1. Leone, L.A., Meitner, P.A., Myers, T.J., Grace, W.R., Gajewski, W.H., Fingert, H.J. & Rotman, B. (1991) Predictive value of the fluorescent cytoprint assay (FCA): A retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy. Cancer Invest, 9, 491-503.

2. Beksac, M., Kansu, E., Kars, A., Ibrahimoglu, Z. & Firat, D. (1988) A rapid drug sensitivity assay for neoplasmatic cells. Med Oncol Tumor Pharmacother, 5, 253-257.

3. Bosanquet, A.G. (1991) Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay. Lancet, 337, 711-716.

4. Hongo, T., Fujii, Y. & Igarashi, Y. (1990) An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer, 65, 1263-1272.

5. Bosanquet, A.G. (1996) Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DISC assay methodology. Leuk Res, 20:143-153, 1996

6. Kaspers, G.J.L., Pieters, R., Van Zantwijk, C.H., De Waal, F.C., Van Wering, E.R. & Veerman, A.J.P. (1993) Is resistance to prednisolone in vitro related to the response to predniso(lo)ne in vivo at initial diagnosis in childhood acute lymphoblastic leukemia? - a preliminary analysis. In: Drug Resistance in Leukemia and Lymphoma, pp. 321-328. Ed. Kaspers, G.J.L., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Chur.

7. Larsson, R., Kristensen, J., Sandberg, C. & Nygren, P. (1992) Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA). Int J Cancer, 50, 177-185.

8. Lathan, B., von Tettau, M., Verpoort, K. & Diehl, V. (1990) Pretherapeutic drug testing in acute leukemias for prediction of individual prognosis. Haematology and Blood Transfusion, 33, 295-298.

9. Weisenthal, L.M., Dill, P.L., Finklestein, J.Z., Duarte, T.E., Baker, J.A. & Moran, E.M. (1986) Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat Rep, 70, 1283-1295.

10. Weisenthal, L.M., Marsden, J.A., Dill, P.L. & Macaluso, C.K. (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res, 43, 749-757.

11. Kirkpatrick, D.L., Duke, M. & Goh, T.S. (1990) Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leuk Res, 14, 459-466.

12. Langkjer, S.T. & Norgaard, J.M. (1993) Use of the MTT-assay for evaluation of chemosensitivity in adult acute myeloid leukemia. In: Drug Resistance in Leukemia and Lymphoma, pp. 279-291. Ed. Kaspers, G.J., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Chur.

13. Santini, V., Bernabei, P.A., Dal Pozzo, O., Santini, S. & Rossi Ferrini, P. (1993) Acute myeloid leukemia (AML) sensitivity to antiblastics is predictable by INT assay. In: Drug Resistance in Leukemia and Lymphoma, pp. 365-368. Ed. Kaspers, G.J., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Chur.

14. Sargent, J.M. & Taylor, C.G. (1989) Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer, 60, 206-10.

15. Larsson, R., Jonsson, B., Kristensen, J., Oberg, G., Simonsson, B., Sundstrom, C., Lonnerholm, G., Kreuger, A., Glimelius, B., Hagberg, H. & Nygren, P. (1993) Drug sensitivity testing of tumor cells from patients with acute leukemia and non-Hodgkin's lymphoma using a fluorometric microculture cytotoxicity assay. In: Drug Resistance in Leukemia and Lymphoma, pp. 399-407. Ed. Kaspers, G.J.L., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Chur.

16. Hongo, T., Fujii, Y. & Yajima, S. (1993) In vitro chemosensitivity of childhood leukemic cells and the clinical value of assay directed chemotherapy. In: Drug resistance in leukemia and lymphoma, pp. 319. Ed. Kaspers, G.J.L., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Langhorne, PA.

17. Santini, V., Bernabei, P.A., Silvestro, L., Dal Pozzo, O., Bezzini, R., Viano, I., Gattei, V., Saccardi, R. & Ferrini, P.R. (1989) In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia. HematolOncol, 7, 287-93.

18. Tidefelt, U., Sundman-Engberg, B., Rhedin, A.S. & Paul, C. (1989) In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations. Eur J Haematol, 43, 374-384.

19. Blackman, K.E., Fingert, H.J., Fuller, A.F. & Meitner, P.A. (1994) The Fluorescent Cytoprint Assay in gynecologic malignancies and breast cancer: methodology and results. Contrib Gynecol Obstet 19, 53-64

20. Koechli, O.R., Avner, B.P., Sevin, B.-U., Avner, B., Perras, J.P., Robinson, D.S. & Averette, H.E. (1993) Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results. J SurgOncol, 54, 119-125.

21. Silber, R., Degar, B., Costin, D., Newcomb, E.W., Mani, M., Rosenberg, C.R., Morse, L., Drygas, J.C., Canellakis, Z.N. & Potmesil, M. (1994) Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood, 84, 3440-3446.

22. Bosanquet, A.G. (1993) The DiSC assay - 10 years and 2000 tests further on. In: Drug Resistance in Leukemia and Lymphoma, pp. 373-383. Ed. Kaspers, G.J.L., Pieters, R., Twentyman, P.R., Weisenthal, L.M. & Veerman, A.J.P. Harwood Academic Publishers, Chur.

23. Asanuma, F., Yamada, Y., Kawamura, E., Kurokawa, T., Lee, K.E., Yamada, T., Suzuki, T., Suzuki, Y., Fujinaga, S. & Kubota, T. (1992) [Comparison between clinical response and in vitro chemosensitivity of solid tumors in the succinic dehydrogenase inhibition test]. Gan To Kagaku Ryoho (Japanese Journal of Cancer), 19, 95-101.

24. Furukawa,T., Kubota,T., and Hoffman, R.M. (1995) Clinical applications of the histoculture drug response assay. Clin Cancer Res 1, 305-311

25. Meitner, P.A. (1991) The fluorescent cytoprint assay: a new approach to in vitro chemosensitivity testing. Oncology (USA), 5, 75-81;.

26. Furukawa, T., Kubota, T., Suto, A., Takahara, T., Yamaguchi, H., Takeuchi, T., Kase, S., Kodaira, S., Ishibiki, K. & Kitajima, M. (1991) Clinical usefulness of chemosensitivity testing using the MTT assay. J Surg Oncol, 48, 188-193.

27. Nygren, P., Hagberg, H., Glimelius, B., Sundstrom, C., Kristensen, J., Christiansen, I. & Larsson, R. (1994) In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay. Ann Oncol, 5 Suppl 1, S127-S131.

28. Smit, E.F., De Vries, E.G.E., Meijer, C., Mulder, N.H. & Postmus, P.E. (1991) Limitations of the fast green assay for chemosensitivity testing in human lung cancer. Chest, 100, 1358-1363.

29. Wilbur, D.W., Camacho, E.S., Hilliard, D.A., Dill, P.L. & Weisenthal, L.M. (1992) Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. Br J Cancer, 65, 27-32.

30. Carstensen, H. & Tholander, B. (1985) Chemosensitivity of ovarian carcinoma: In vitro/in vivo correlations using the dye exclusion assay of Weisenthal (meeting abstract). Proceedings: 3rd European Conference on Clinical Oncology, Stockholm, p. 206.

31. Sargent, J., Elgie, A., Taylor, C.G., Wilson, J., Alton, P. & Hill, J.G. (1994) The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay. Contrib Gynecol Obstet 19, 64-75

32. Sevin, B.-U., Perras, J.P., Averette, H.E., Donato, D.M. & Penalver, M. (1993) Chemosensitivity testing in ovarian cancer. Cancer, 71, 1613-1620.

33. Sevin, B.-U., Perras, J.P. & Koechli, O.R. (1994) Current status and future directions of chemosensitivity testing. Contrib Gynecol Obstet 19, 179-194

34. Cree, I.A., Kurbacher, C.M., Untch, M., et al. (1996) Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anti-Cancer Drugs 7, 630-635

35. Taylor, C.G., Sargent, J.M., Elgie, A.W., et al. (1998) The clinical relevance of chemosensitivity testing in ovarian cancer. Cancer Detect Prev 22, 305-12